Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.38
+0.29 (4.09%)
At close: Feb 26, 2026, 4:00 PM EST
7.02
-0.36 (-4.89%)
After-hours: Feb 26, 2026, 4:56 PM EST
Climb Bio Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$12.20
Upside
+65.31%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $23 | Buy | Initiates | $23 | +211.65% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +49.05% | Dec 18, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +8.40% | Oct 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +21.95% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +8.40% | Sep 30, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -5.15% | Sep 22, 2025 |
| Baird | Baird | Buy Initiates $9 | Buy | Initiates | $9 | +21.95% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +35.50% | Jun 6, 2025 |